News | 01 June 2012
LINCOLNSHIRE, Ill., May 31, 2012 (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) announced today that it intends to effect a reverse split of its common stock and class C special stock at a ratio of 1-for-6. The reverse stock split will ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)